![Riccardo Panella](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Riccardo Panella
Chief Tech/Sci/R&D Officer at Resalis Therapeutics SRL
Riccardo Panella active positions
Companies | Position | Start | End |
---|---|---|---|
Resalis Therapeutics SRL
![]() Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti. | Director/Board Member | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Career history of Riccardo Panella
Statistics
International
Italy | 2 |
Operational
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Resalis Therapeutics SRL
![]() Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Resalis Therapeutics SRL is a company that focuses on developing a transformative metabolic disease approach to target obesity and fatty liver disease. The company is based in Turin, Italy. The Italian company's lead program, RES-010, is a safe and convenient treatment that provides disease-modifying therapeutic impact, including durable weight loss and reduction of hepatic steatosis. The CEO of the company is Eva Castagnetti. | Commercial Services |
- Stock Market
- Insiders
- Riccardo Panella
- Experience